Blog: News
Explore PYFA’s end-to-end CDMO solutions, from product development and formulation to manufacturing, regulatory support, and market access—helping pharmaceutical partners bring innovative products to market efficiently across Indonesia and Asia-Pacific.
Surging Running Trend Prompts Pyridam Farma (PYFA) to Urge Indonesian Runners to Protect Joints and Bones Early On
Pyridam Farma (PYFA) Expands Access to Lipid Disorder Therapies, Supporting Cardiovascular Risk Factor Management
PYFA Distributes Tens of Thousands of Vitamin Supplements to Support Health Recovery for Disaster Victims in NTT and Kalimantan
Three Months Post-Launch: PYFAESTHETIC’s Collost Native Collagen Surpasses 2,500 Treatments
Pyridam Farma (PYFA) Excels in CDMO Services, Accelerates Expansion of Capacity and Capabilities
With Indonesian Pharmacists Association, PYFA Advances National Pharmaceutical Resilience
PYFA’s Probiotec Achieves Green Star 6-Star Rating, Reinforcing ESG Commitment in Sustainable Building
Pyridam Farma (PYFA) Records 16.8% Revenue Growth, Operating Loss Shrinks by 99.4% in H1 2026
Addressing Sports-Related Muscle Injuries: PYFA Health Launches X-Cool Powered by European Cold-Therapy Technology
